Testing and development of peroxide disinfectant
| Reference number | |
| Coordinator | ALRON CHEMICAL CO AKTIEBOLAG |
| Funding from Vinnova | SEK 1 090 677 |
| Project duration | November 2014 - May 2016 |
| Status | Completed |
Purpose and goal
Alron has successfully developed new formulations of our peroxide (Odox, Odox +, Maxox-PF, Penetrox-S and Penetrox-PF) which will be introduced on the market in autumn, 2016. An important advantage of these new formulations is that they can be registered according to the EU Biocides Directive (BPR), which now applies to hydrogen peroxide and Alron has initiated this very costly and complicated registration process
Expected results and effects
Alron has successfully developed new formulations of our peroxide (Odox, Odox +, Maxox-PF, Penetrox-S and Penetrox-PF) which will be introduced on the market in autumn, 2016. An important advantage of these new formulations is that they can be registered according to the EU Biocides Directive (BPR), which now applies to hydrogen peroxide and Alron has initiated this very costly and complicated registration process. A successful outcome will provide Alron a huge competitive advantage
Planned approach and implementation
Despite initial difficulties, the project has been very successful and the original objectives have been achieved.